Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus
Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus
type Iand Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Human T-lymphotropic virus
1: clinical aspects of a neglected infection among indigenous populations.
Detection of Human T-Lymphotropic Virus
Type I (HTLV-I) Infection during Coculture of HTLV-I Infected and Uninfected Cells Using Inverse Long PCR.
Prevention of mother-to-child transmission of human T-lymphotropic virus
Current trends update: Public Health Service Workshop on Human T-Lymphotropic Virus
Type III Antibody Testing--United States.
The Food and Drug Administration mandates certain screening tests for blood--including tests for Hepatitis B surface antigen (HBsAg), Hepatitis B core antibody (anti-HBc), Hepatitis C Virus (HCV) antibody (anti-HCV), Human Immunodeficiency Virus (HIV) types 1 and 2 (anti-HIV-1 and anti-HIV-2), Human T-Lymphotropic Virus
(HTLV) types I and II (anti-HTLV-I and anti-HTLV-II), serologic test for syphilis, Nucleic Acid Amplification Testing (NAT) for HIV-1 and HCV, and NAT for West Nile Virus.
Shimian Zou of the American Red Cross in Rockville, Maryland and colleagues analyzed data from 11,391 tissue donors at 5 US tissue banks between 2000 and 2002 to assess the probability of undetected HIV, HBV, HCV, and human T-lymphotropic virus
3] Nonstandard abbreviations: HTLV-I, human T-lymphotropic virus
type I; PA, particle agglutination; ATL, adult T-cell leukemia; HAM/TSP, HTLVI-associated myelopathy/tropical spastic paraparesis; CIA, counting immunoassay; and COI, cutoff index.
Results of serologic tests for HIV, Epstein-Barr virus (EBV), human T-lymphotropic virus
1, and human T-lymphotropic virus
2 were negative.
The application claimed that the cell line might prove useful for the treatment of human T-lymphotropic virus
(HTLV), which is associated with a form of leukemia and a degenerative nerve disease.
The application claimed that the cell line might prove useful for the treatment of the Human T-lymphotropic virus
, or HTLV, which is associated with a form of leukemia and a degenerative nerve disease.
Currently, MPEP focuses on antibody testing for human immunodeficiency virus type I (HIV-1), human T-lymphotropic virus
types I and II (HTLV-I/II), and T-lymphocyte immunophenotyping by flow cytometry.
Elaine DeFreitas and her co-workers at the Wistar Institute in Philadelphia used three types of tests with 30 people suffering from CFIDS and found that the majority of the volunteers showed some sign of infection by human T-lymphotropic virus
type II (HTLV-II), a suspect in a rare form of leukemia.